Sponsored by:

Nuclear Medicine: Page 54

USP delays revised radiopharmaceutical standards
By AuntMinnie.com staff writers
The U.S. Pharmacopeial Convention (USP) has postponed until December 1 implementation of several revisions related to the compounding, preparation, and packaging of radiopharmaceuticals.
September 25, 2019
2019 08 15 20 38 9073 Patient Safety 400
Rethinking Ga-68 PSMA-11 PET/CT for bone metastases
By Wayne Forrest
Researchers from the University of California, Los Angeles say it is time to reconsider guidelines in favor of broader use of gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET/CT to detect bone metastases in prostate cancer patients, based on findings in their study published September 20 in the Journal of Nuclear Medicine.
September 25, 2019
2018 05 16 22 58 8356 Cancer Cell Target2 400
GE, partners to develop PET tracers
By AuntMinnie.com staff writers
GE Healthcare is teaming up with three companies and one U.S. academic institution to develop a portfolio of PET tracers designed to better predict and monitor patient response to immunotherapies.
September 24, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
Technologist licensure bill introduced in Pa.
By AuntMinnie.com staff writers
A bill that would require licensure for medical imaging and radiation therapy technologists has been introduced in the Pennsylvania Legislature, according to the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
September 22, 2019
SNMMI sets submission schedule for 2020 meeting
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has adjusted its schedule for abstract submissions for its 2020 annual meeting.
September 17, 2019
2018 05 22 18 57 9927 Snmmi Logo 400
FDA OK's Mayo Clinic cyclotron
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has approved the opening of a cyclotron facility at the Mayor Clinic in Jacksonville, FL.
September 17, 2019
GE inks deal for imaging antibodies
By AuntMinnie.com staff writers
GE Healthcare has signed a licensing agreement with Australian biotech company AdAlta to develop antibodies for diagnostic imaging.
September 17, 2019
2019 02 05 17 15 4430 Ge Rsna 2018 400
More Mo-99 production woes at ANSTO
By AuntMinnie.com staff writers
A mechanical problem at the Australian Nuclear Science and Technology Organisation's (ANSTO) Lucas Heights nuclear medicine facility has again forced the medical isotope maker to curtail production.
September 12, 2019
2018 12 11 00 02 7009 Atom Nuclear Lab 400
PET, MRI link amyloid plaque with swift decline
By Wayne Forrest
Patients whose PET and MR images show beta-amyloid plaque accumulation in the brain experience a significantly faster path toward dementia than people with vascular dementia and no plaque deposits, according to a study published online September 11 in Neurology.
September 11, 2019
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
Ga-68 PSMA PET/MRI, mpMRI work for prostate cancer analysis
By Wayne Forrest
Prostate cancer patients at intermediate or high risk of advanced disease can benefit from either gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/MRI or multiparametric MRI (mpMRI) alone to diagnose specific features of their disease, according to a study published September 10 in Radiology.
September 11, 2019
2017 06 15 10 31 55 42 Prostate 400
Digirad acquires modular housing firm
By AuntMinnie.com staff writers
Digirad is expanding its portfolio beyond nuclear medicine equipment and services with the acquisition of ATRM Holdings, a manufacturer of commercial and residential modular housing units.
September 10, 2019
Blue Earth touts talks at ASTRO 2019
By AuntMinnie.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics is directing attention to several presentations at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) later this week in Chicago.
September 10, 2019
Previous Page
Page 54 of 440
Next Page